News

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the…
Read More...

Trovagene announced that the European Commission (EC) has endorsed the positive opinion of the Committee for Orphan Medicinal Products (COMP) and has granted Orphan Drug Designation…
Read More...

SGS announced it is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland with a new 200m2 laboratory. The laboratory will be equipped with a number of…
Read More...

Sirona Biochem Corp. announced that it has received the $500,000 USD milestone payment from partner Wanbang Biopharmaceuticals Co., Ltd for approval by the China Food and Drug…
Read More...

KBI Biopharma, Inc. announced that its subsidiary KBI Biopharma BVBA has begun operations at its newly completed laboratories in Leuven, Belgium. The laboratories are co-located with…
Read More...

Novasep announces that its API development and manufacturing site in Chasse-sur-Rhône, France, has been successfully inspected by the US Food and Drug Administration (FDA). The…
Read More...

Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development. Through this partnership, both companies…
Read More...

Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic…
Read More...

Novartis announced that the European Commission (EC) has approved Kymriah (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pediatric and young…
Read More...

Adverum Biotechnologies announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ADVM-053, a preclinical gene therapy candidate…
Read More...

JW Pharmaceutical and LEO Pharma A/S announced that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma, a…
Read More...

Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy…
Read More...

Roche announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa (alectinib) as a monotherapy treatment for patients with anaplastic…
Read More...

AstraZeneca announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tagrisso(osimertinib) for the 1st-line treatment of patients with inoperable or…
Read More...

Innovate Biopharmaceuticals announced it signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase 3 celiac disease trial.…
Read More...

PTC Therapeutics announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative…
Read More...

bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy. Gritstone Oncology will…
Read More...

AGC Biologics announced that as part of its global expansion strategy, the company is increasing manufacturing capacity at its Copenhagen, Denmark facility. The Copenhagen facility…
Read More...

The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer…
Read More...

Revive Therapeutics Ltd. announced that it has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation of cannabidiol for the treatment of…
Read More...